Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease
Background: Aldosterone antagonists may mediate their effects on heart failure through parathyroid hormone (PTH) in chronic kidney disease (CKD) patients. Methods: Patients with CKD on spironolactone were selected and matched for age, gender, race, use of a vitamin D analogue, the number of antihype...
Main Authors: | Mona Hassan, Waqas Qureshi, Laila S Sroujieh, Derar Albashaireh, Sara BouMalham, Meghan Liroff, Waseem Amjad, Fatima Khalid, Hiba Hadid, Zaid Alirhayim |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2014-09-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320314539180 |
Similar Items
-
The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01) -
The Importance of Correlation between Aldosterone and Parathyroid Hormone in Patients with Primary Hyperparathyroidism
by: Branka Milicic Stanic, et al.
Published: (2022-01-01) -
ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01) -
Aldosterone Antagonist Dosing and the Risk of Hyponatremia in Patients With Cirrhosis and Ascites
by: A.S. Vogel, et al.
Published: (2023-01-01) -
Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System
by: Nejla Latic, et al.
Published: (2022-12-01)